# The Combination of Adductor Canal Block and Periarticular Injection. A Novel Technique for Patients Undergoing Total Knee Replacement (ACB PAI)

> **NCT02292082** · PHASE4 · COMPLETED · sponsor: **Hospital for Special Surgery, New York** · enrollment: 111 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** Bupivacaine
- **DRUG:** Morphine
- **DRUG:** Methylprednisolone
- **DRUG:** Cefazolin
- **DRUG:** Normal saline
- **DRUG:** Midazolam
- **DRUG:** Propofol
- **DRUG:** Dexamethasone
- **DEVICE:** 8 MHz. Chiba needle, 22 G / 4 inches

## Key facts

- **NCT ID:** NCT02292082
- **Lead sponsor:** Hospital for Special Surgery, New York
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2019-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02292082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02292082, "The Combination of Adductor Canal Block and Periarticular Injection. A Novel Technique for Patients Undergoing Total Knee Replacement (ACB PAI)". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT02292082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*